StreetInsider.com News Articles

StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 23 Jul 2026 03:29:16 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Evotec selects Navan to manage travel and expense globally http://www.streetinsider.com/Corporate+News/Evotec+selects+Navan+to+manage+travel+and+expense+globally/26803312.html <p>Navan (NASDAQ: NAVN) announced that Evotec (NASDAQ: EVO), a drug discovery and development company, has selected its platform to manage corporate travel and expense programs across its top global markets.</p><p>Evotec had previously managed travel and expense independently across different countries, relying on a mix of tools and manual processes. The company is now rolling out Navan across Germany, the UK, the U.S., Italy, and France.</p><p>The platform is intended to automate expense reconciliation from the point of transaction, replacing manual data entry and consolidating travel booking and expense management into a single system.</p><p>"Simplifying processes and strengthening operational excellence while enabling our http://www.streetinsider.com/Corporate+News/Evotec+selects+Navan+to+manage+travel+and+expense+globally/26803312.html Thu, 23 Jul 2026 03:29:16 -0400 EVO EVT NAVN Evotec selects Navan to manage travel and expense globally http://www.streetinsider.com/Corporate+News/Evotec+selects+Navan+to+manage+travel+and+expense+globally/26803312.html <p>Navan (NASDAQ: NAVN) announced that Evotec (NASDAQ: EVO), a drug discovery and development company, has selected its platform to manage corporate travel and expense programs across its top global markets.</p><p>Evotec had previously managed travel and expense independently across different countries, relying on a mix of tools and manual processes. The company is now rolling out Navan across Germany, the UK, the U.S., Italy, and France.</p><p>The platform is intended to automate expense reconciliation from the point of transaction, replacing manual data entry and consolidating travel booking and expense management into a single system.</p><p>"Simplifying processes and strengthening operational excellence while enabling our http://www.streetinsider.com/Corporate+News/Evotec+selects+Navan+to+manage+travel+and+expense+globally/26803312.html Thu, 23 Jul 2026 03:29:16 -0400 EVO EVT NAVN Evotec selects Navan to manage travel and expense globally http://www.streetinsider.com/Corporate+News/Evotec+selects+Navan+to+manage+travel+and+expense+globally/26803312.html <p>Navan (NASDAQ: NAVN) announced that Evotec (NASDAQ: EVO), a drug discovery and development company, has selected its platform to manage corporate travel and expense programs across its top global markets.</p><p>Evotec had previously managed travel and expense independently across different countries, relying on a mix of tools and manual processes. The company is now rolling out Navan across Germany, the UK, the U.S., Italy, and France.</p><p>The platform is intended to automate expense reconciliation from the point of transaction, replacing manual data entry and consolidating travel booking and expense management into a single system.</p><p>"Simplifying processes and strengthening operational excellence while enabling our http://www.streetinsider.com/Corporate+News/Evotec+selects+Navan+to+manage+travel+and+expense+globally/26803312.html Thu, 23 Jul 2026 03:29:16 -0400 EVO EVT NAVN Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management http://www.streetinsider.com/Press+Releases/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html <p class="bwalignc"> <i>Global drug discovery leader partners with Navan to drive operational excellence and eliminate manual expense reporting</i> </p> <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnavan.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Navan&index=1&md5=c440f2ff087f511fd4ceda4869b0c0a0" shape="rect">Navan</a> (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.evotec.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Evotec&index=2&md5=730c50c98c2e258e6926390bcdb5ef67" shape="rect">Evotec</a> (NASDAQ: EVO; Frankfurt Prime Standard: EVT), the global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program in its top global markets. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260722261092/en/" rel="nofollow">https://www.businesswire.com/news/home/20260722261092/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260722261092/en/2857609/4/Evotec_Press_Release_Graphic.jpg" http://www.streetinsider.com/Press+Releases/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html Thu, 23 Jul 2026 03:00:00 -0400 A.50203688 EVO EVT NAVN O.00002050 O.00233944 Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management http://www.streetinsider.com/Press+Releases/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html <p class="bwalignc"> <i>Global drug discovery leader partners with Navan to drive operational excellence and eliminate manual expense reporting</i> </p> <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnavan.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Navan&index=1&md5=c440f2ff087f511fd4ceda4869b0c0a0" shape="rect">Navan</a> (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.evotec.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Evotec&index=2&md5=730c50c98c2e258e6926390bcdb5ef67" shape="rect">Evotec</a> (NASDAQ: EVO; Frankfurt Prime Standard: EVT), the global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program in its top global markets. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260722261092/en/" rel="nofollow">https://www.businesswire.com/news/home/20260722261092/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260722261092/en/2857609/4/Evotec_Press_Release_Graphic.jpg" http://www.streetinsider.com/Press+Releases/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html Thu, 23 Jul 2026 03:00:00 -0400 A.50203688 EVO EVT NAVN O.00002050 O.00233944 Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management http://www.streetinsider.com/Press+Releases/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html <p class="bwalignc"> <i>Global drug discovery leader partners with Navan to drive operational excellence and eliminate manual expense reporting</i> </p> <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnavan.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Navan&index=1&md5=c440f2ff087f511fd4ceda4869b0c0a0" shape="rect">Navan</a> (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.evotec.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Evotec&index=2&md5=730c50c98c2e258e6926390bcdb5ef67" shape="rect">Evotec</a> (NASDAQ: EVO; Frankfurt Prime Standard: EVT), the global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program in its top global markets. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260722261092/en/" rel="nofollow">https://www.businesswire.com/news/home/20260722261092/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260722261092/en/2857609/4/Evotec_Press_Release_Graphic.jpg" http://www.streetinsider.com/Press+Releases/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html Thu, 23 Jul 2026 03:00:00 -0400 A.50203688 EVO EVT NAVN O.00002050 O.00233944 Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management http://www.streetinsider.com/Press+Releases/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html <p class="bwalignc"> <i>Global drug discovery leader partners with Navan to drive operational excellence and eliminate manual expense reporting</i> </p> <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnavan.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Navan&index=1&md5=c440f2ff087f511fd4ceda4869b0c0a0" shape="rect">Navan</a> (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.evotec.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Evotec&index=2&md5=730c50c98c2e258e6926390bcdb5ef67" shape="rect">Evotec</a> (NASDAQ: EVO; Frankfurt Prime Standard: EVT), the global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program in its top global markets. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260722261092/en/" rel="nofollow">https://www.businesswire.com/news/home/20260722261092/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260722261092/en/2857609/4/Evotec_Press_Release_Graphic.jpg" http://www.streetinsider.com/Press+Releases/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html Thu, 23 Jul 2026 03:00:00 -0400 A.50203688 EVO EVT NAVN O.00002050 O.00233944 Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management http://www.streetinsider.com/Press+Releases/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html <p class="bwalignc"> <i>Global drug discovery leader partners with Navan to drive operational excellence and eliminate manual expense reporting</i> </p> <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnavan.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Navan&index=1&md5=c440f2ff087f511fd4ceda4869b0c0a0" shape="rect">Navan</a> (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.evotec.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Evotec&index=2&md5=730c50c98c2e258e6926390bcdb5ef67" shape="rect">Evotec</a> (NASDAQ: EVO; Frankfurt Prime Standard: EVT), the global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program in its top global markets. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260722261092/en/" rel="nofollow">https://www.businesswire.com/news/home/20260722261092/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260722261092/en/2857609/4/Evotec_Press_Release_Graphic.jpg" http://www.streetinsider.com/Press+Releases/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html Thu, 23 Jul 2026 03:00:00 -0400 A.50203688 EVO EVT NAVN O.00002050 O.00233944 Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management http://www.streetinsider.com/Press+Releases/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html <p class="bwalignc"> <i>Global drug discovery leader partners with Navan to drive operational excellence and eliminate manual expense reporting</i> </p> <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnavan.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Navan&index=1&md5=c440f2ff087f511fd4ceda4869b0c0a0" shape="rect">Navan</a> (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.evotec.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Evotec&index=2&md5=730c50c98c2e258e6926390bcdb5ef67" shape="rect">Evotec</a> (NASDAQ: EVO; Frankfurt Prime Standard: EVT), the global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program in its top global markets. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260722261092/en/" rel="nofollow">https://www.businesswire.com/news/home/20260722261092/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260722261092/en/2857609/4/Evotec_Press_Release_Graphic.jpg" http://www.streetinsider.com/Press+Releases/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html Thu, 23 Jul 2026 03:00:00 -0400 A.50203688 EVO EVT NAVN O.00002050 O.00233944 Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management http://www.streetinsider.com/Business+Wire/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html <p class="bwalignc"> <i>Global drug discovery leader partners with Navan to drive operational excellence and eliminate manual expense reporting</i> </p> <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnavan.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Navan&index=1&md5=c440f2ff087f511fd4ceda4869b0c0a0" shape="rect">Navan</a> (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.evotec.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Evotec&index=2&md5=730c50c98c2e258e6926390bcdb5ef67" shape="rect">Evotec</a> (NASDAQ: EVO; Frankfurt Prime Standard: EVT), the global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program in its top global markets. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260722261092/en/" rel="nofollow">https://www.businesswire.com/news/home/20260722261092/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260722261092/en/2857609/4/Evotec_Press_Release_Graphic.jpg" http://www.streetinsider.com/Business+Wire/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html Thu, 23 Jul 2026 03:00:00 -0400 A.50203688 EVO EVT NAVN O.00002050 O.00233944 Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management http://www.streetinsider.com/Business+Wire/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html <p class="bwalignc"> <i>Global drug discovery leader partners with Navan to drive operational excellence and eliminate manual expense reporting</i> </p> <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnavan.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Navan&index=1&md5=c440f2ff087f511fd4ceda4869b0c0a0" shape="rect">Navan</a> (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.evotec.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Evotec&index=2&md5=730c50c98c2e258e6926390bcdb5ef67" shape="rect">Evotec</a> (NASDAQ: EVO; Frankfurt Prime Standard: EVT), the global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program in its top global markets. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260722261092/en/" rel="nofollow">https://www.businesswire.com/news/home/20260722261092/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260722261092/en/2857609/4/Evotec_Press_Release_Graphic.jpg" http://www.streetinsider.com/Business+Wire/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html Thu, 23 Jul 2026 03:00:00 -0400 A.50203688 EVO EVT NAVN O.00002050 O.00233944 Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management http://www.streetinsider.com/Business+Wire/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html <p class="bwalignc"> <i>Global drug discovery leader partners with Navan to drive operational excellence and eliminate manual expense reporting</i> </p> <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnavan.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Navan&index=1&md5=c440f2ff087f511fd4ceda4869b0c0a0" shape="rect">Navan</a> (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.evotec.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Evotec&index=2&md5=730c50c98c2e258e6926390bcdb5ef67" shape="rect">Evotec</a> (NASDAQ: EVO; Frankfurt Prime Standard: EVT), the global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program in its top global markets. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260722261092/en/" rel="nofollow">https://www.businesswire.com/news/home/20260722261092/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260722261092/en/2857609/4/Evotec_Press_Release_Graphic.jpg" http://www.streetinsider.com/Business+Wire/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html Thu, 23 Jul 2026 03:00:00 -0400 A.50203688 EVO EVT NAVN O.00002050 O.00233944 Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management http://www.streetinsider.com/Business+Wire/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html <p class="bwalignc"> <i>Global drug discovery leader partners with Navan to drive operational excellence and eliminate manual expense reporting</i> </p> <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnavan.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Navan&index=1&md5=c440f2ff087f511fd4ceda4869b0c0a0" shape="rect">Navan</a> (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.evotec.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Evotec&index=2&md5=730c50c98c2e258e6926390bcdb5ef67" shape="rect">Evotec</a> (NASDAQ: EVO; Frankfurt Prime Standard: EVT), the global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program in its top global markets. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260722261092/en/" rel="nofollow">https://www.businesswire.com/news/home/20260722261092/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260722261092/en/2857609/4/Evotec_Press_Release_Graphic.jpg" http://www.streetinsider.com/Business+Wire/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html Thu, 23 Jul 2026 03:00:00 -0400 A.50203688 EVO EVT NAVN O.00002050 O.00233944 Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management http://www.streetinsider.com/Business+Wire/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html <p class="bwalignc"> <i>Global drug discovery leader partners with Navan to drive operational excellence and eliminate manual expense reporting</i> </p> <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnavan.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Navan&index=1&md5=c440f2ff087f511fd4ceda4869b0c0a0" shape="rect">Navan</a> (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.evotec.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Evotec&index=2&md5=730c50c98c2e258e6926390bcdb5ef67" shape="rect">Evotec</a> (NASDAQ: EVO; Frankfurt Prime Standard: EVT), the global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program in its top global markets. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260722261092/en/" rel="nofollow">https://www.businesswire.com/news/home/20260722261092/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260722261092/en/2857609/4/Evotec_Press_Release_Graphic.jpg" http://www.streetinsider.com/Business+Wire/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html Thu, 23 Jul 2026 03:00:00 -0400 A.50203688 EVO EVT NAVN O.00002050 O.00233944 Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management http://www.streetinsider.com/Business+Wire/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html <p class="bwalignc"> <i>Global drug discovery leader partners with Navan to drive operational excellence and eliminate manual expense reporting</i> </p> <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnavan.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Navan&index=1&md5=c440f2ff087f511fd4ceda4869b0c0a0" shape="rect">Navan</a> (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.evotec.com%2F&esheet=54575105&newsitemid=20260722261092&lan=en-US&anchor=Evotec&index=2&md5=730c50c98c2e258e6926390bcdb5ef67" shape="rect">Evotec</a> (NASDAQ: EVO; Frankfurt Prime Standard: EVT), the global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program in its top global markets. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260722261092/en/" rel="nofollow">https://www.businesswire.com/news/home/20260722261092/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260722261092/en/2857609/4/Evotec_Press_Release_Graphic.jpg" http://www.streetinsider.com/Business+Wire/Evotec+Selects+Navan+to+Unify+Global+Travel%2C+Payments%2C+and+Expense+Management/26803263.html Thu, 23 Jul 2026 03:00:00 -0400 A.50203688 EVO EVT NAVN O.00002050 O.00233944 Evotec AG (EVT:GR) (EVO) PT Lowered to EUR3.50 at Deutsche Bank http://www.streetinsider.com/Intl+Ratings/Evotec+AG+%28EVT%3AGR%29+%28EVO%29+PT+Lowered+to+EUR3.50+at+Deutsche+Bank/26776282.html Deutsche Bank analyst Falko Friedrichs lowered the price target on Evotec AG (EVT:GR) (NASDAQ: EVO) to EUR3.50 (from EUR4.50) while maintaining a Hold rating. http://www.streetinsider.com/Intl+Ratings/Evotec+AG+%28EVT%3AGR%29+%28EVO%29+PT+Lowered+to+EUR3.50+at+Deutsche+Bank/26776282.html Thu, 16 Jul 2026 06:46:21 -0400 EVO Evotec AG (EVT:GR) (EVO) PT Lowered to EUR3.50 at Deutsche Bank http://www.streetinsider.com/Intl+Ratings/Evotec+AG+%28EVT%3AGR%29+%28EVO%29+PT+Lowered+to+EUR3.50+at+Deutsche+Bank/26776282.html Deutsche Bank analyst Falko Friedrichs lowered the price target on Evotec AG (EVT:GR) (NASDAQ: EVO) to EUR3.50 (from EUR4.50) while maintaining a Hold rating. http://www.streetinsider.com/Intl+Ratings/Evotec+AG+%28EVT%3AGR%29+%28EVO%29+PT+Lowered+to+EUR3.50+at+Deutsche+Bank/26776282.html Thu, 16 Jul 2026 06:46:21 -0400 EVO Evotec AG (EVT:GR) (EVO) PT Lowered to EUR3.50 at Deutsche Bank http://www.streetinsider.com/Analyst+PT+Change/Evotec+AG+%28EVT%3AGR%29+%28EVO%29+PT+Lowered+to+EUR3.50+at+Deutsche+Bank/26776282.html Deutsche Bank analyst Falko Friedrichs lowered the price target on Evotec AG (EVT:GR) (NASDAQ: EVO) to EUR3.50 (from EUR4.50) while maintaining a Hold rating. http://www.streetinsider.com/Analyst+PT+Change/Evotec+AG+%28EVT%3AGR%29+%28EVO%29+PT+Lowered+to+EUR3.50+at+Deutsche+Bank/26776282.html Thu, 16 Jul 2026 06:46:21 -0400 EVO Evotec AG (EVT:GR) (EVO) PT Lowered to EUR3.50 at Deutsche Bank http://www.streetinsider.com/Analyst+PT+Change/Evotec+AG+%28EVT%3AGR%29+%28EVO%29+PT+Lowered+to+EUR3.50+at+Deutsche+Bank/26776282.html Deutsche Bank analyst Falko Friedrichs lowered the price target on Evotec AG (EVT:GR) (NASDAQ: EVO) to EUR3.50 (from EUR4.50) while maintaining a Hold rating. http://www.streetinsider.com/Analyst+PT+Change/Evotec+AG+%28EVT%3AGR%29+%28EVO%29+PT+Lowered+to+EUR3.50+at+Deutsche+Bank/26776282.html Thu, 16 Jul 2026 06:46:21 -0400 EVO Berenberg Downgrades Evotec AG (EVT:GR) (EVO) to Hold http://www.streetinsider.com/Intl+Ratings/Berenberg+Downgrades+Evotec+AG+%28EVT%3AGR%29+%28EVO%29+to+Hold/26775393.html <p>Berenberg analyst Christian Ehmann downgraded Evotec AG (EVT:GR) (NASDAQ: EVO) from Buy to Hold with a price target of EUR3.60 (from EUR9.40).</p><p>The analyst comments: “Guidance downgrade exposes deep reliance on uncontracted deals: Evotec has delivered a disappointment with its preliminary H1 2026 results by significantly cutting its FY 2026 guidance. Group revenues are now projected at EUR570m-610m and adjusted group EBITDA has been cut to -EUR70m to EUR105m. This new guidance compares unfavourably to the pre-event consensus estimates of EUR730m sales and EUR33m adjusted EBITDA. The guidance downgrade is primarily driven by shifting timelines, as the company expects those revenues http://www.streetinsider.com/Intl+Ratings/Berenberg+Downgrades+Evotec+AG+%28EVT%3AGR%29+%28EVO%29+to+Hold/26775393.html Thu, 16 Jul 2026 01:52:25 -0400 EVO Berenberg Downgrades Evotec AG (EVT:GR) (EVO) to Hold http://www.streetinsider.com/Intl+Ratings/Berenberg+Downgrades+Evotec+AG+%28EVT%3AGR%29+%28EVO%29+to+Hold/26775393.html <p>Berenberg analyst Christian Ehmann downgraded Evotec AG (EVT:GR) (NASDAQ: EVO) from Buy to Hold with a price target of EUR3.60 (from EUR9.40).</p><p>The analyst comments: “Guidance downgrade exposes deep reliance on uncontracted deals: Evotec has delivered a disappointment with its preliminary H1 2026 results by significantly cutting its FY 2026 guidance. Group revenues are now projected at EUR570m-610m and adjusted group EBITDA has been cut to -EUR70m to EUR105m. This new guidance compares unfavourably to the pre-event consensus estimates of EUR730m sales and EUR33m adjusted EBITDA. The guidance downgrade is primarily driven by shifting timelines, as the company expects those revenues http://www.streetinsider.com/Intl+Ratings/Berenberg+Downgrades+Evotec+AG+%28EVT%3AGR%29+%28EVO%29+to+Hold/26775393.html Thu, 16 Jul 2026 01:52:25 -0400 EVO Berenberg Downgrades Evotec AG (EVT:GR) (EVO) to Hold http://www.streetinsider.com/Downgrades/Berenberg+Downgrades+Evotec+AG+%28EVT%3AGR%29+%28EVO%29+to+Hold/26775393.html <p>Berenberg analyst Christian Ehmann downgraded Evotec AG (EVT:GR) (NASDAQ: EVO) from Buy to Hold with a price target of EUR3.60 (from EUR9.40).</p><p>The analyst comments: “Guidance downgrade exposes deep reliance on uncontracted deals: Evotec has delivered a disappointment with its preliminary H1 2026 results by significantly cutting its FY 2026 guidance. Group revenues are now projected at EUR570m-610m and adjusted group EBITDA has been cut to -EUR70m to EUR105m. This new guidance compares unfavourably to the pre-event consensus estimates of EUR730m sales and EUR33m adjusted EBITDA. The guidance downgrade is primarily driven by shifting timelines, as the company expects those revenues http://www.streetinsider.com/Downgrades/Berenberg+Downgrades+Evotec+AG+%28EVT%3AGR%29+%28EVO%29+to+Hold/26775393.html Thu, 16 Jul 2026 01:52:25 -0400 EVO Berenberg Downgrades Evotec AG (EVT:GR) (EVO) to Hold http://www.streetinsider.com/Downgrades/Berenberg+Downgrades+Evotec+AG+%28EVT%3AGR%29+%28EVO%29+to+Hold/26775393.html <p>Berenberg analyst Christian Ehmann downgraded Evotec AG (EVT:GR) (NASDAQ: EVO) from Buy to Hold with a price target of EUR3.60 (from EUR9.40).</p><p>The analyst comments: “Guidance downgrade exposes deep reliance on uncontracted deals: Evotec has delivered a disappointment with its preliminary H1 2026 results by significantly cutting its FY 2026 guidance. Group revenues are now projected at EUR570m-610m and adjusted group EBITDA has been cut to -EUR70m to EUR105m. This new guidance compares unfavourably to the pre-event consensus estimates of EUR730m sales and EUR33m adjusted EBITDA. The guidance downgrade is primarily driven by shifting timelines, as the company expects those revenues http://www.streetinsider.com/Downgrades/Berenberg+Downgrades+Evotec+AG+%28EVT%3AGR%29+%28EVO%29+to+Hold/26775393.html Thu, 16 Jul 2026 01:52:25 -0400 EVO Berenberg Downgrades Evotec AG (EVT:GR) (EVO) to Hold http://www.streetinsider.com/Analyst+Comments/Berenberg+Downgrades+Evotec+AG+%28EVT%3AGR%29+%28EVO%29+to+Hold/26775393.html <p>Berenberg analyst Christian Ehmann downgraded Evotec AG (EVT:GR) (NASDAQ: EVO) from Buy to Hold with a price target of EUR3.60 (from EUR9.40).</p><p>The analyst comments: “Guidance downgrade exposes deep reliance on uncontracted deals: Evotec has delivered a disappointment with its preliminary H1 2026 results by significantly cutting its FY 2026 guidance. Group revenues are now projected at EUR570m-610m and adjusted group EBITDA has been cut to -EUR70m to EUR105m. This new guidance compares unfavourably to the pre-event consensus estimates of EUR730m sales and EUR33m adjusted EBITDA. The guidance downgrade is primarily driven by shifting timelines, as the company expects those revenues http://www.streetinsider.com/Analyst+Comments/Berenberg+Downgrades+Evotec+AG+%28EVT%3AGR%29+%28EVO%29+to+Hold/26775393.html Thu, 16 Jul 2026 01:52:25 -0400 EVO Berenberg Downgrades Evotec AG (EVT:GR) (EVO) to Hold http://www.streetinsider.com/Analyst+Comments/Berenberg+Downgrades+Evotec+AG+%28EVT%3AGR%29+%28EVO%29+to+Hold/26775393.html <p>Berenberg analyst Christian Ehmann downgraded Evotec AG (EVT:GR) (NASDAQ: EVO) from Buy to Hold with a price target of EUR3.60 (from EUR9.40).</p><p>The analyst comments: “Guidance downgrade exposes deep reliance on uncontracted deals: Evotec has delivered a disappointment with its preliminary H1 2026 results by significantly cutting its FY 2026 guidance. Group revenues are now projected at EUR570m-610m and adjusted group EBITDA has been cut to -EUR70m to EUR105m. This new guidance compares unfavourably to the pre-event consensus estimates of EUR730m sales and EUR33m adjusted EBITDA. The guidance downgrade is primarily driven by shifting timelines, as the company expects those revenues http://www.streetinsider.com/Analyst+Comments/Berenberg+Downgrades+Evotec+AG+%28EVT%3AGR%29+%28EVO%29+to+Hold/26775393.html Thu, 16 Jul 2026 01:52:25 -0400 EVO